Pediatric SLE-towards a comprehensive management plan

Hermine I. Brunner, Jennifer Huggins, Marisa S Klein-Gitelman

Research output: Contribution to journalReview article

36 Citations (Scopus)

Abstract

Systemic lupus erythematosus (SLE) results from complex abnormalities of the innate and acquired immune systems. For reasons that are currently not well understood, the disease course and phenotype associated with SLE, although quite variable, are generally more severe when the diagnosis is made during childhood. Active disease, infections, lupus nephritis, and neuropsychiatric SLE manifestations are associated with higher morbidity and mortality. Unlike in adult-onset SLE, systemic glucocorticoid therapy and immunosuppressive medications are needed for the treatment of the majority of children and adolescents with SLE. The complex nature of childhood-onset SLE demands a comprehensive, multidisciplinary management approach that considers the patients' growth and development, their educational needs, and the unpredictable course of SLE and its complications.

Original languageEnglish (US)
Pages (from-to)225-233
Number of pages9
JournalNature Reviews Rheumatology
Volume7
Issue number4
DOIs
StatePublished - Apr 1 2011

Fingerprint

Systemic Lupus Erythematosus
Pediatrics
Central Nervous System Lupus Vasculitis
Lupus Nephritis
Immunosuppressive Agents
Growth and Development
Glucocorticoids
Immune System
Morbidity
Phenotype
Mortality
Therapeutics
Infection

ASJC Scopus subject areas

  • Rheumatology

Cite this

Brunner, Hermine I. ; Huggins, Jennifer ; Klein-Gitelman, Marisa S. / Pediatric SLE-towards a comprehensive management plan. In: Nature Reviews Rheumatology. 2011 ; Vol. 7, No. 4. pp. 225-233.
@article{72f4a8635c0e42d0ae5401e1f68ea682,
title = "Pediatric SLE-towards a comprehensive management plan",
abstract = "Systemic lupus erythematosus (SLE) results from complex abnormalities of the innate and acquired immune systems. For reasons that are currently not well understood, the disease course and phenotype associated with SLE, although quite variable, are generally more severe when the diagnosis is made during childhood. Active disease, infections, lupus nephritis, and neuropsychiatric SLE manifestations are associated with higher morbidity and mortality. Unlike in adult-onset SLE, systemic glucocorticoid therapy and immunosuppressive medications are needed for the treatment of the majority of children and adolescents with SLE. The complex nature of childhood-onset SLE demands a comprehensive, multidisciplinary management approach that considers the patients' growth and development, their educational needs, and the unpredictable course of SLE and its complications.",
author = "Brunner, {Hermine I.} and Jennifer Huggins and Klein-Gitelman, {Marisa S}",
year = "2011",
month = "4",
day = "1",
doi = "10.1038/nrrheum.2011.15",
language = "English (US)",
volume = "7",
pages = "225--233",
journal = "Nature reviews. Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",
number = "4",

}

Pediatric SLE-towards a comprehensive management plan. / Brunner, Hermine I.; Huggins, Jennifer; Klein-Gitelman, Marisa S.

In: Nature Reviews Rheumatology, Vol. 7, No. 4, 01.04.2011, p. 225-233.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pediatric SLE-towards a comprehensive management plan

AU - Brunner, Hermine I.

AU - Huggins, Jennifer

AU - Klein-Gitelman, Marisa S

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Systemic lupus erythematosus (SLE) results from complex abnormalities of the innate and acquired immune systems. For reasons that are currently not well understood, the disease course and phenotype associated with SLE, although quite variable, are generally more severe when the diagnosis is made during childhood. Active disease, infections, lupus nephritis, and neuropsychiatric SLE manifestations are associated with higher morbidity and mortality. Unlike in adult-onset SLE, systemic glucocorticoid therapy and immunosuppressive medications are needed for the treatment of the majority of children and adolescents with SLE. The complex nature of childhood-onset SLE demands a comprehensive, multidisciplinary management approach that considers the patients' growth and development, their educational needs, and the unpredictable course of SLE and its complications.

AB - Systemic lupus erythematosus (SLE) results from complex abnormalities of the innate and acquired immune systems. For reasons that are currently not well understood, the disease course and phenotype associated with SLE, although quite variable, are generally more severe when the diagnosis is made during childhood. Active disease, infections, lupus nephritis, and neuropsychiatric SLE manifestations are associated with higher morbidity and mortality. Unlike in adult-onset SLE, systemic glucocorticoid therapy and immunosuppressive medications are needed for the treatment of the majority of children and adolescents with SLE. The complex nature of childhood-onset SLE demands a comprehensive, multidisciplinary management approach that considers the patients' growth and development, their educational needs, and the unpredictable course of SLE and its complications.

UR - http://www.scopus.com/inward/record.url?scp=79953669202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953669202&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2011.15

DO - 10.1038/nrrheum.2011.15

M3 - Review article

VL - 7

SP - 225

EP - 233

JO - Nature reviews. Rheumatology

JF - Nature reviews. Rheumatology

SN - 1759-4790

IS - 4

ER -